Verdinexor
Verdinexor (KPT-335, KPT335) is an orally bioavailable, selective inhibitor of nuclear export (SINE), inhibits the function of nuclear export protein Exportin 1 (XPO1/CRM1) and the viability of Jurkat and canine DLBCL cells with IC50 of 8.7 nM and 13.3 nM, respectively; induces apoptosis in CLBL1 cells and primary canine DLBCL cells; reduces influenza a virus replication in vitro and in vivo; also inhibits XPO1-mediated transport and reduces RSV replication in vitro, shows effectivity against RSV A and B strains and reduces viral replication following prophylactic or therapeutic administration.Influenza Phase 1 Clinical.
Product Specifications
CAS Number
1392136-43-4
Product Name Alternative
KPT-335 | KPT335
Purity
>98% (HPLC)
Solubility
DMSO: 82 mg/mL (185.4 mM) ; Ethanol: 9 mg/mL (20.3 mM) (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (NNC1=NC=CC=C1) /C=C\N2N=C (C3=CC (C (F) (F) F) =CC (C (F) (F) F) =C3) N=C2
Molecular Formula
C19H13F6N5O
Molecular Weight
441.337
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(Z) -3- (3- (3,5-bis (trifluoromethyl) phenyl) -1H-1,2,4-triazol-1-yl) -N- (pyridin-2-ylmethyl) acrylamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Heat Shock Protein 27, phosphorylated (Ser78) (HSP27) (MaxLight 750) discontinued
Mouse ITGb2 (Integrin Beta 2) Microsample ELISA Kit